Vizgen, Inc., a leader in spatial multi-omics at single-cell resolution, today announced a series of innovations under development to help accelerate drug discovery, advance understanding of disease ...
Department of Chemistry and Biochemistry, University of South Carolina, Columbia, United States ...
Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players—NF-κB, IL-6, STAT3, TAMs, MDSCs, and ...
Risk prediction has been used in the primary prevention of cardiovascular disease for >3 decades. Contemporary cardiovascular risk assessment relies on multivariable models, which integrate ...
The market is fueled by the technology’s ability to map biomolecules and cellular interactions within tissues, enabling precision diagnostics, early disease detection, and targeted treatment ...
In Pick’s disease, as in Alzheimer’s disease and frontotemporal dementia, tangled tau spells trouble. In this subtype of FTD, abnormal clumps of three-repeat tau called Pick bodies abound in neurons.
How many times a week do you introduce yourself? Whether it’s in person, virtually, one-on-one, in a large group, or formally or informally, you probably introduce yourself many times a week. Perhaps ...
This is read by an automated voice. Please report any issues or inconsistencies here. Los Angeles-based Athos Therapeutics, Inc., an AI software and clinical stage biotechnology company pioneering the ...
Nearly 50 new cancer therapies are approved every year. While this positive trend is a huge benefit for patients, Altuna Akalin, PhD, head of the bioinformatics and omics data science technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results